Panel on social and ethical issues in cancer prevention and therapy

Activity of pirarubicin (4'-0-tetrahydropyranyladriamycin) in malignant mesothelioma.

Cancer·1989

Correlation of in vitro clonogenic assay data with in vivo growth delays and cell cycle changes of a human melanoma xenograft.

Cancer research·1983

Effect of cholesterol content on antitumor activity and toxicity of liposome-encapsulated 1-beta-D-arabinofuranosylcytosine in vivo.

Cancer research·1980

Vincristine effect on methotrexate cerebrospinal fluid concentration.

Cancer treatment reports·1979

Selective toxicity of anticancer drugs: Presidential Address.

Cancer research·1978

Combining talents for the management of cancer patients.

Cancer·1975

Malawi pilot study of Burkitt lymphoma treatment.

Medical and pediatric oncology·2003

Epigenetic changes in the DAP-kinase CpG island in pediatric lymphoma.

Medical and pediatric oncology·2003

Differences in vasculature between pilocytic and anaplastic astrocytomas of childhood.

Medical and pediatric oncology·2003

Functional Brain Network Alterations Linked to Cancer-Related Cognitive Impairment in Breast Cancer Patients.

The oncologist·2026

A phase II multi-institutional single arm trial evaluating TG4010 vaccine plus nivolumab in non-small cell lung cancer.

Oncoimmunology·2026

Intravesical gemcitabine versus Bacillus Calmette-Guérin (BCG) for intermediate-/high-risk non-muscle-invasive bladder cancer during the BCG shortage: Safety, efficacy, and health-economic context.

Investigative and clinical urology·2026

Feasibility of Single-Session Whole-Liver Yttrium-90 Radioembolization for Multifocal Hepatocellular Carcinoma.

Korean journal of radiology·2026

Cemiplimab in cutaneous squamous cell carcinoma: a longer follow-up study focusing on the late toxicities.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026

Not all anti-CD38 antibodies are created equal: The epitope of felzartamab is partially DTT-resistant.

Transfusion medicine (Oxford, England)·2026

Related Experiment Videos

Panel on social and ethical issues in cancer prevention and therapy

Related Concept Videos

Activity of pirarubicin (4'-0-tetrahydropyranyladriamycin) in malignant mesothelioma.

Correlation of in vitro clonogenic assay data with in vivo growth delays and cell cycle changes of a human melanoma xenograft.

Effect of cholesterol content on antitumor activity and toxicity of liposome-encapsulated 1-beta-D-arabinofuranosylcytosine in vivo.

Vincristine effect on methotrexate cerebrospinal fluid concentration.

Selective toxicity of anticancer drugs: Presidential Address.

Combining talents for the management of cancer patients.

Malawi pilot study of Burkitt lymphoma treatment.

Epigenetic changes in the DAP-kinase CpG island in pediatric lymphoma.

Differences in vasculature between pilocytic and anaplastic astrocytomas of childhood.

Functional Brain Network Alterations Linked to Cancer-Related Cognitive Impairment in Breast Cancer Patients.

A phase II multi-institutional single arm trial evaluating TG4010 vaccine plus nivolumab in non-small cell lung cancer.

Intravesical gemcitabine versus Bacillus Calmette-Guérin (BCG) for intermediate-/high-risk non-muscle-invasive bladder cancer during the BCG shortage: Safety, efficacy, and health-economic context.

Feasibility of Single-Session Whole-Liver Yttrium-90 Radioembolization for Multifocal Hepatocellular Carcinoma.

Cemiplimab in cutaneous squamous cell carcinoma: a longer follow-up study focusing on the late toxicities.

Not all anti-CD38 antibodies are created equal: The epitope of felzartamab is partially DTT-resistant.

Related Experiment Videos

Panel on social and ethical issues in cancer prevention and therapy

Related Concept Videos

Related Articles